Huntington's disease (HD) is a devastating neurodegenerative disorder caused by an expanded polyglutamine (polyQ) tract within the huntingtin protein (Htt). Identifying the pathways that are altered in response to the mutant protein is crucial for understanding the cellular processes impacted by the disease as well as for the rational development of effective pharmacological interventions. Here, expression profiling of a cellular HD model identifies genes that implicate altered mitogen-activated protein kinase (MAPK) signaling. Targeted biochemical studies and pharmacological modulation of these MAPK pathways suggest that mutant Htt affects signaling at upstream points such that both ERK and JNK are activated. Modulation of the ERK pathway suggests that this pathway is associated with cell survival, whereas inhibition of JNK was found to effectively suppress pathogenesis. These studies suggest that pharmacological intervention in MAPK pathways, particularly at the level of ERK activation, may be an appropriate approach to HD therapy.
INTRODUCTION
Several late-onset neurodegenerative diseases, including Huntington's disease (HD), are caused by expansions of CAG repeats encoding polyglutamine (polyQ) tracts within the corresponding disease protein (1, 2) . The polyQ repeats elicit a complex pathogenic response in neuronal cells, the mechanisms of which are not fully understood (3 -5) . One common feature is the appearance of polyQ-containing visible aggregates in the affected regions of the brain, likely a result of abnormal protein folding and/or proteolytic cleavage of the Htt protein (6, 7) . Neurons and other cell types respond to external or internal stimuli, such as oxidative stress or abnormal protein folding and aggregation by activating cellular signal transduction networks, including the mitogen-activated protein kinases (MAPKs), to elicit pro-survival and pro-apoptotic responses (8) . The MAPK superfamily comprises three major signaling pathways: the extracellular signal-regulated protein kinases (ERKs), the c-Jun N-terminal kinases or stressactivated protein kinases (JNKs/SAPKs) and the p38 family of kinases. Following a cascade of phosphorylation events that initially activate upstream effectors (e.g. MEKKs), the individual MAPKs are in turn phosphorylated and regulate transcriptional events either directly or by catalyzing phosphorylation of nuclear regulatory proteins (8 -10) .
MAPK signaling has been implicated in a number of neurodegenerative disorders, including HD. Early work using cell culture models showed that mutant Htt might cause activation of growth # The Author 2005. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org { These authors contributed equally to this work. *To whom correspondence should be addressed at: Gillespie 2121, University of California, Irvine, CA 92697-4260. Tel: þ 1 949 824 6756. Email: lmthompson@uci.edu factor receptor signaling through direct interactions with signaling entities such as Grb2 and Ras-GAP (11) . In contrast, other cell-based studies showed that expression of mutant Htt can lead to attenuated growth factor signaling (12, 13) , and a recent study in Drosophila showed that expression of mutant Htt can disrupt EGF receptor signaling (14) .
Here we describe gene expression profiling of an inducible PC12 cell line expressing mutant Htt. Prominent among the genes whose expression is altered in response to mutant Htt are groups of genes that are known targets of the MAPKs: ERK1/2 (hereafter ERK), JNK and p38 that suggest induction of both neurotrophic and cell death pathways in mutant Htt-expressing cells. Consistent with the predicted MAPK activation, phosphorylation patterns of ERK and JNK are altered in cell models of HD. Inhibition of ERK activation confirms a role for this pathway in the observed gene expression changes, and the functional relevance of ERK and JNK activation is confirmed in targeted biochemical studies and through chemical modulation of these pathways. The functional relevance of these pathways has implications for novel therapeutic applications for HD.
RESULTS

Microarray analysis of PC12 cells expressing truncated mutant Htt suggests activation of MAPK pathways
To investigate processes that are relatively early pathogenic events as opposed to later death-related events, gene expression profiling was performed on inducible mutant Htt-expressing cells that become dysfunctional but continue to proliferate. A clonal rat pheochromocytoma (PC12) cell line, (Htt14A2.5), which expresses a truncated form of expanded repeat Htt exon 1 protein, fused at the C-terminus to enhanced green fluorescent protein (EGFP) (Httex1tr-103Q-EGFP) (Fig. 1A) , was selected for robust inducible Htt expression and the production of visible aggregates (cytosolic, perinuclear and nuclear inclusions) (15) . No obvious cell death or growth arrest phenotypes were observed using a variety of cell toxicity and proliferation assays in the presence and absence of exogenously applied stresses (15) (data not shown). However, when tested for caspase 3 activity, an indicator of cellular dysfunction (16) , Htt14A2.5 cells induced with ponasterone (PA) show a progressive increase in activity up to 4 days following induction relative to control cells. In a representative experiment, caspase 3 activity increased 2.3-fold between induced and uninduced cells 4 days after induction (discussed subsequently, Fig. 3B ). Similar assays were performed following nerve growth factor (NGF) treatment to induce PC12 cell differentiation, and no significant differences were noted in caspase 3 activity between differentiated and proliferating cells (data not shown). No increased caspase 3 activity was observed in the parental PC12ec receptor line in the presence of PA (data not shown), suggesting that this increase is specific to Htt expression as opposed to other non-Htt-related cellular events. Other studies have also reported that expression of mutant Htt causes increased caspase 3 activity (17, 18) . Thus, increased caspase 3 levels appear to be an early response to mutant Htt expression prior to overt cell death.
Gene expression analysis was performed on induced Htt14A2.5 cells relative to uninduced controls 48 h postinduction, a time point in which caspase 3 activity is increased, but prior to when cell density and other factors might complicate interpretation of results. As a control, expression profiling was performed on the parental receptor line, PC12ec, which expresses the ecdysone receptor alone. This control line showed differential expression of only one gene [increased: VGF (vacinia virus inducible growth factor), GenBank accession no. M74223], confirming that hormone induction alone does not significantly contribute to gene expression alterations observed upon mutant Htt expression. The complete data set is available through NCBI GEO Database accession no. GSE2602.
After probe pairs encoding identical genes were combined, 192 gene expression differences were noted (107 increased and 75 decreased) ( Table 1) . Genes from expressed sequence tags (ESTs) without a well-established biochemical function or which show only moderate or weak similarity to a known gene were not further evaluated (Supplementary Material,  Table S1A and B), leaving 85 increased and 53 decreased mRNAs for further evaluation. Of these altered genes, only 20% (17/85) of the mRNAs that increased exhibited a !3-fold change, whereas the majority of the changes were relatively small. This was also true for the mRNAs that decreased, where only 3.8% (2/53) exhibited a 3-fold change. Altered genes were sorted into broad functional groups to simplify discussion and several patterns emerged. One group of genes whose expression increased encodes proteins classically associated with stress responses (Table 1) . Included in this class are several molecular chaperones: Hsp70, Hsp27 and BiP/GRP78 that are involved in facilitating proper protein-folding in the cytosol and endoplasmic reticulum. Also included are mRNAs that encode proteins involved in the reduction of reactive oxygen species: glutathione S-transferase (GST, multiple subunits), thiol-specific antioxidant (peroxiredoxin) and cathespin L. A second class of genes includes those associated with apoptosis, particularly p53-regulated genes, including GADD34, GADD45 and p21 WAF1/CIP1 . We also observed an increase in caspase 3 expression consistent with the increase in caspase 3 activity discussed earlier.
Within the groups of altered genes, many are identified as genes upregulated in response to ERK, JNK and/or p38 Figure 1 . Htt constructs used in this study. (A) Httex1tr-103Q-EGFP encodes the first 17 amino acids of Htt with 103Qs fused to EGFP and was used to generate inducible Htt14A2.5 line (truncated exon 1). (B) Httex1-103QP-EGFP encodes the same sequence as in Httex1tr-103Q-EGFP, except that it includes the 'proline-rich' region of Htt (complete exon1) and was used to generate the Htt 103 line. (C) Htt548 (Q18 and Q120) contains the first 548 amino acids of the Htt gene with either 18Qs (wild-type) or 120Qs (mutant) lengths of the polyglutamine stretch and these were used to generate the N548 wt and N548mu lines, respectively. signaling, such as ATF3, c-jun, egr-1, Fra-1, Hsp27, MKP-3, PAI-1, VEGF-D, GAP-43 and u-PAR (19 -21) . Among the increased genes, there is extensive overlap with upregulated genes specific to NGF treatment of PC12 cells, including several tyrosine or dual specificity phosphatases (e.g. 3CH134/CL100 PTPase/MKP-1, dual specificity phosphatase 6/MKP-3, uPAR-1, egr-1, c-jun and Fra-1) (20) . Genes that overlap with NGF treatment are annotated in Table 1 . These results suggest that the expression of Htt mimics the intracellular transcriptional responses induced by cellular stress (e.g. oxidative stress) and growth factor (e.g. NGF) stimulation through MAPK signaling. Genes whose expression was decreased can also be sorted into broad functional classes (Table 1) . A notable group of mRNAs that were decreased includes genes encoding proteins involved in DNA replication and repair and chromosome structure. Interestingly, decreases in the expression of this class of genes are typically associated with either heat shock responses or cell cycle arrest and apoptosis similar to that observed with activation of MAPK and/or p53 pathways (22) . We also detected the decreased expression of several isoforms of nuclear factor 1 (NF1), a group of transcription factors that have previously been shown to be repressed by stress in HepG2 cells (23) . Similar classes of genes have been identified in other HD model systems (24, 25) .
Gene expression changes were verified by testing 13 altered mRNAs and one unchanged mRNA (EF1-a), using northern blot analysis (Supplementary Material, Fig. S1 ). A high confirmation rate between northern blot analysis and microarray results was found (13/13), although the absolute fold changes varied (Fig. 2) . Specifically, GST-YB-2, Creatine kinase (brain), Diacylglycerol kinase, GTP cyclohydrolase, p21 WAF1/CIP1 , Taurine transporter, Egr-1, GAP-43, Fra-1 and MKP-1 mRNAs were confirmed as increased, and angiotensin II type 2 receptor, DNA topoisomerase IIa and PCNA mRNAs were confirmed as decreased. Calcium-independent alpha-latrotoxin receptor homolog 2
21.6
Affymetrix U34A GeneChips were hybridized to target cRNA from Htt14A2.5 cells induced for 48 h with PA or uninduced and genes listed were called changed in MAS v5.0 in at least 75% of the pairwise comparisons. Multiple probe pair sets were identified for several genes and the corresponding GenBank accession nos are given. FC refers to the average fold change values determined in MAS v5.0 for all possible pairwise comparisons and for all probe pair sets identified. Genes with average fold changes less than 21.5 or greater than þ1.5 were not considered. (A) and (B) include genes with increased and decreased expression, respectively. The asterisk indicates genes altered by NGF treatment (20) .
Expression of mutant Htt causes increased activation of JNK in PC12 and ST14A cells which parallels toxicity
As described earlier, a notable group of genes whose transcription is altered is that which can be upregulated in response to stress-or growth factor-induced activation of signaling pathways including the MAPKs JNK, ERK and p38. These pathways tend to regulate pro-apoptotic and pro-survival responses of the cell. To determine which signaling pathways might be modulated by mutant Htt expression, we first examined the phosphorylation status of two MAPKs typically associated with cell death in mammalian cells JNK and p38. Htt14A2.5 cells were induced for 48 h, when transgene expression and inclusion formation are maximal. Levels of activated (i.e. phosphorylated) forms of these proteins were evaluated by immunoblotting, using antibodies that detect the phospho-and total-protein forms. Phospho-JNK (p-JNK) levels increased slightly over a 48 h time course, showing an approximate 2-fold increase (Fig. 3A) . A progressive increase in caspase 3 activation was observed over time, corresponding to the observed JNK activation (Fig. 3B) . Phospho-p38 levels were unchanged (data not shown). Similar increases in the parental PC12ec line were not observed at the corresponding time points (data not shown). For an independent measure of JNK kinase activity, the ability of p-JNK in cell lysates to phosphorylate an exogenously added substrate, GST-c-jun(1 -79), was measured. In a representative experiment (Fig. 3C) , at 2 days post-induction the level of JNK kinase activity was 1.6-fold higher in induced cells, and at 3 days this ratio was 1.7-fold. These results are consistent with immunoblot analysis showing elevated p-JNK. To confirm that JNK has a role in the observed Htt-mediated cell dysfunction, the contribution of activated JNK to caspase 3 activation was investigated by treating Htt14A2.5 cells with a competitive inhibitor of JNK, SP600125 (26) . Cells were simultaneously induced and treated with SP600125 for 48 h. In the presence of the inhibitor, caspase 3 activity was reduced by 21% (Fig. 3D) . Levels of the downstream target of JNK, c-jun, were evaluated by immunoblot analysis to verify inhibition of JNK activity (Fig. 3E) . In both uninduced and induced Htt14A2.5 cells, p-c-jun levels are decreased in the presence of SP600125. Taken together, these results suggest that JNK activation may contribute to the cellular dysfunction observed in the presence of mutant Htt.
To determine whether Htt-dependent increases in p-JNK are unique to this cell line or common to other mutant Httexpressing cells, the Htt14A2.5 line was compared with Htt 103 (Fig. 1B) , an independent, inducible, mutant Htt exon1 (Httex1-103QP-EGFP)-expressing PC12 line that exhibits extensive and rapid cell death (27) . These PC12 cells exhibit 55% cell death as measured by LDH activity after 48 h (data not shown), an 2.5-fold increase in caspase 3 activity after 48 h of induction with PA ( Fig. 4B ) and 6.8-fold increase after 72 h of induction (Fig. 4B) . Consistent with a greater increase in caspase 3 activity, the Htt 103 line exhibits a more rapid and higher level of p-JNK (Fig. 4A ), beginning at 4 h, peaking by 8 h and remaining at an 15-fold increased level up to 48 h. Later measurements were not possible due to cell death.
Finally, we examined p-JNK levels in ST14A cells: a conditionally immortalized striatal-derived line that expresses a 548-amino acid N-terminal segment of either wild-type (N548wt) or mutant (N548mu) human Htt (Fig. 1C) (28) . These cells constitutively express Htt; however, they contain a temperature-sensitive large T-antigen, which, upon shifting cells to the non-permissive temperature (398C), is inactivated and cells stop dividing and partially differentiate. Upon expression of mutant Htt (N548mu), cells show rapid cell death (28) . Consistent with significant levels of cell death, p-JNK levels were dramatically increased in the N548mu line relative to N548 wt or the parental ST14A cells (Fig. 4C) . To confirm that increased p-JNK correlates with cell dysfunction and death, both caspase 3 activation and MTT were assessed. Upon simultaneous shift to 398C and to serum deprived media (SDM) for 12 h, control, N548 wt and N548mu cells all demonstrate increased caspase 3 activation; however, N548mu cells show a significantly higher activation than controls (.2-fold, Fig. 4D ). As cell death in this line is so prominent, we were unable to use caspase 3 activity as a measure of dysfunction for periods longer than 16 h following temperature and media shift. Using MTT assays, N548mu cells undergo dramatic cell death when simultaneously shifted to 398C and to SDM over a 3-day time course (Fig. 4E) .
In summary, three separate cell lines expressing various regions of Htt support the hypothesis that levels of activated JNK directly correlate with the extent of Htt-associated cell death.
Expression of mutant Htt causes sustained activation of ERK in PC12 and ST14A cells
In the PC12 Htt14A2.5 line, gene expression profiling suggests that pro-survival signaling responses are induced in Human
addition to pro-cell death responses upon expression of mutant Htt and that these pathways may act together to produce the relatively mild cell dysfunction observed. Therefore, we examined the activation of two kinases associated with signaling pathways typically involved in cell survival: the MAPKs ERK and AKT (29, 30) . In the Htt14A2.5 cells, in response to Htt challenge, phospho-ERK (p-ERK) levels increased over time to a maximum at 24 h and were elevated 5-fold relative to uninduced cells (Fig. 5A) . AKT levels were unchanged (data not shown). To confirm that the phosphorylation results from the immunoblot analysis correspond to increases in ERK kinase activity, we performed direct measurements of the levels of activated ERK in induced versus uninduced cells using the Stratagene PathDetect Trans-Reporting System, which measures the ability of ERK to activate an Elk1 fusion protein resulting in luciferase production. After 3 days induction, ERK kinase activity was 6-fold higher in induced cells than in uninduced cells (Fig. 5D) . We also measured the levels of p-ERK in the Htt 103 line over a 48 h time course. Similar to the Htt14A2.5 line, p-ERK showed an increase in induced cells over the 48 h period, but to a lesser extent (Fig. 5B) . In these cells, a higher basal level of p-ERK with a moderate increase in p-ERK was observed beginning at 4 h and reaching 2-4-fold maximal levels by 8-12 h. Finally, p-ERK levels were also elevated at the permissive temperature (338C) in the N548mu cells relative to the parental ST14A or to the N548 wt lines (3-fold relative to ST14A, Fig. 5C ). We did not observe a change in the level of p-ERK when cells were shifted to the non-permissive temperature and SDM in any of the lines (data not shown), likely because of the rapid cell death that occurs. These results are consistent with a role for ERK in cell survival and suggest a possible compensatory mechanism by the cell to counteract the deleterious effects of mutant Htt expression.
As described earlier, gene expression changes identified in the microarray analysis indicated alterations in the expression of a number of genes that can be regulated by MAPKs, including several associated with ERK (Fra-1, Egf-1 and GAP-43) (20) . To determine whether the increased expression of a subset of these genes could be directly associated with the increase in ERK activation, we performed northern blot analysis to examine the levels of Fra-1, Egf-1 and GAP-43 mRNAs in induced cells in the presence of U0126, a specific inhibitor of MEK1/2 (MEK), which is the upstream kinase of ERK. Cells were induced for 24 h followed by an additional 24 h of treatment with 0, 1 or 103 (Httex1-103QP-EFGP expressing) cells were induced with 2 mM PA for the indicated times and 75 mg of total protein was electrophoresed on 10% SDS-polyacrylamide gels and probed with phospho-JNK specific antibody followed by reprobing with total JNK antibody. (B) Caspase 3 activity was determined at the indicated times and expressed as the ratio of induced to uninduced cells. (C) ST14A, N548wt (Htt548-Q18) and N548mu (Htt548-Q120) cells were grown under the permissive condition (338C and CM) overnight and then shifted to the non-permissive condition (398C and SDM) for 1 day. Immunoblots were performed as described in (A). (D) Caspase 3 assays were performed 16 h after shifting cells to the non-permissive conditions and expressed as a ratio of cells grown at 338C in CM to those grown at 398C in SDM. (E) MTT assays were performed on the ST14A, N548wt and N548mu lines at the indicated times after shifting to non-permissive conditions. Cellular MTT was solubilized and absorbance was determined at 570 nm. Caspase 3 and MTT assays were performed in triplicate and experiments were repeated at least three times. Graphs are the mean and SE from a representative experiment. 103 cells were induced with 5 or 2 mM PA, respectively, and harvested at the indicated times. Twenty-five micrograms of total protein was electrophoresed on 12% SDS-polyacrylamide gels and probed with phospho-ERK specific antibody followed by stripping and reprobing with antibody detecting total ERK. The doublets represent different gene products (e.g. ERK 1 and 2) that are activated in a similar manner and both are recognized by the indicated antibodies. The two proteins, represented by the two bands, are independently phosphorylated. Although activation of both proteins is typically observed simultaneously and shows the same trends, absolute levels of phosphorylation may not always increase to the same degree. (C) ST14A, N548 wt and N548mu cells were grown at 338C in CM overnight, harvested and immunoblots performed as described earlier. (D) Uninduced Htt14A2.5 cells or cells induced with 5 mM PA were transiently transfected with pFA2-Elk1 and pFR-Luc plasmids. Two days later (3 days of post-induction), cells were lysed and luciferase assays were performed. RLUs are expressed per milligram of total protein. (E) Htt14A2.5 cells were induced with 5 mM PA for 24 h followed by addition of the indicated concentrations of U0126 for an additional 24 h. Northern blots were performed using probes specific for the indicated genes and blots were quantitated using phosphoimager scanning and normalization for loading differences by stripping and reprobing with EF1-a (unchanged transcript). Probe sequences are provided in Materials and Methods. 5 mM U0126. Immunoblot analysis confirmed a progressive inhibition of p-ERK under these conditions with no detectable p-ERK at 5 mM. As would be predicted, if gene expression changes were dependent upon ERK activation, the levels of Fra-1, Egf-1 and GAP-43 mRNAs decreased as concentrations of U0126 were increased (Fig. 5E ) (Supplementary Material, Fig. S2) . As a control, MKP-1, whose expression does not appear to be regulated by ERK, was tested. Consistent with a specific role for ERK, increasing concentrations of U0126 had no effect on the level of MKP-1 expression (31). These results suggest that at least a subset of the gene expression changes identified in the microarray analysis and predicted to be due to ERK activation is indeed sensitive to changes in ERK activity levels in the Htt14A2.5 line.
ERK activity is protective against Htt-mediated cell dysfunction in PC12 cells
As the earlier studies suggest a potential protective effect of ERK activation against deleterious cellular effects associated with mutant Htt expression, we investigated whether ERK activation influenced the degree of caspase 3 activation in the Htt14A2.5 line. When ERK activation is prevented by treating cells with 10 mM U0126, a corresponding increase in caspase 3 activity is observed (Fig. 6A) , consistent with a pro-survival function for activated ERK.
To further test the hypothesis that activation of ERK may be protective, the role of ERK was evaluated in the Htt 103 cell line. Owing to the profound cell death phenotype of this line, effects of chemical compounds upon toxicity are difficult to evaluate. Therefore, the effect of overexpressing a constitutively active form of MEK1 (MEK1-CA) in both the Htt14A2.5 and the Htt 103 lines was assessed. The Htt14A2.5 line was induced for 24 h followed by transient transfection with MEK1-CA or control plasmids and cells were harvested 48 h after transfection. As the Htt 103 cells show relatively rapid cell death following induction, these cells were transfected with MEK1-CA-expressing plasmids first, induced with PA 24 h later and then harvested an additional 24 h following induction. Caspase 3 activity was determined, and p-ERK levels were evaluated in both lines (Fig. 6B) . Consistent with the inhibitor results in Htt14A2.5 lines, increasing ERK activity in both PC12 cell lines with MEK1-CA resulted in decreased caspase 3 activity (Fig. 6B -D) .
ERK activity is protective against Htt-mediated cell dysfunction in ST14A cells
As ERK activation is protective in two separate mutant Htt-containing PC12 lines, we next examined whether the increased levels of p-ERK seen in the N548mu line might also served a protective role. At 338C, these cells do not exhibit appreciable cell death; however, p-ERK levels are higher in the N548mu line than in either the ST14A or the N548 wt line, suggesting that either cells are attempting to mount a protective response or ERK is deleterious in these lines. ST14A and N548mu cells were grown under permissive conditions in the presence of increasing concentrations of U0126, and caspase 3 assays were performed 20 h later. Consistent with a protective role for ERK activation, a dose-dependent increase in caspase 3 activity and decreased p-ERK were observed in the N548mu line relative to ST14A parental cells with increasing concentrations of U0126 ( Fig. 6E and F) . These results are consistent with a compensatory upregulation of p-ERK in the proliferating N548mu cell line that constitutively expresses mutant Htt, but is not sufficient to prevent rapid cell death upon transition to non-permissive conditions.
To determine whether additional ERK activation could reduce Htt-associated toxicity when N548mu cells were shifted to 398C and SDM, transient transfections with MEK1-CA were formed as described in Materials and Methods. As shown using MTT assays (Fig. 6G) , increasing the amount of activated ERK genetically decreases toxicity associated with mutant Htt by 2-fold, again consistent with a protective role for ERK.
DISCUSSION
Gene expression profiling and targeted biochemical studies presented here implicate pathways modulated by ERK and JNK signaling in HD pathogenesis. These studies suggest that among potential pathways altered, ERK promotes survival, whereas JNK promotes cell death. Therefore, expression of mutant Htt upregulates both protective and deleterious pathways, and the balance between these opposing pathways determines the ultimate fate of the cell: life or death. The ability to mount a protective response (p-ERK) as opposed to robust activation of cell death-promoting pathways (p-JNK) is reflected in the degree and timing of toxicity and cell death in the cell lines used. The cell line used for the gene expression profiling (Htt14A2.5) seems to reveal early pathogenic and compensatory cellular events as opposed to massive cell death that may reflect later or secondary events. The number of genes altered is moderate with the majority of genes increased in their expression, and changes are largely reflective of simultaneous apopotic and neuroprotective signals elicited by a cell to cope with molecular insults, such as a misfolded protein (1). Our results are distinct from gene expression profiling results from several other HD model systems (both whole animals and cell culture models), in which the number of decreased genes is typically greater than those with increased expression (24, 25, 32, 33) ; however, the results presented here may reflect early events as the cell begins to cope with the mutant Htt insult. In support of the hypothesis that at least some of the gene expression changes reflect compensatory events, the induction of molecular chaperones such as Hsp27, Hsp70 and GRP78 is a classic indicator of stress responses and is generally protective in HD and other polyQ disorders (reviewed in 34-42).
JNK
We observed a positive correlation between the cell dysfunction (i.e. increased caspase 3 activity and/or decreased MTT) and the levels of activated JNK. Treatment with the JNK inhibitor, SP600125, decreased caspase 3 activation and reduced phospho-c-jun levels in the Htt14A2.5 line. In separate studies, SP600125 was also found to rescue photoreceptor Other studies have implicated JNK activation in mutant Htt-associated toxicity as well. For example, JNK has been shown to be activated in primary striatal neurons expressing mutant Htt, and inhibition of this pathway with SP600125 as well as overexpression of a dominant-negative form of c-jun protects against cell death (46) . In immortalized hippocampal cell lines expressing a full-length mutant Htt protein, JNK activation promotes cell death, whereas inhibition of this pathway with a dominant-negative MKK4/SEK1 mutant blocks Htt-mediated apoptosis (47, 48) . JNK activation has also been found in a number of other neurodegenerative disease models including SBMA (49), Alzheimer's (50) and Parkinson's diseases (51). Here we confirm the relationship of JNK activation to mutant Htt-associated toxicity in three different stably transfected cell lines that exhibit varying degrees of cell dysfunction/death. Interference with this activation is protective, suggesting that inhibition of JNK activation might represent a potential therapeutic target.
ERK
Although the role of JNK in mutant Htt-associated toxicity seems relatively straightforward, the role of ERK activation in HD and other neurodegenerative diseases is likely to be more complex, as both protective and deleterious roles for ERK activation in neuronal cells have been described, and the reader is referred to several excellent reviews (19, 52, 53) . In this study, we present novel findings that strongly suggest that activation of ERK elicits pro-survival and protective responses in mutant Htt-expressing cells. In two different PC12 cell lines and in an immortalized striatal neuronal line, we found higher levels of activated ERK in cells expressing mutant Htt when compared with controls. Inhibition of this activated ERK with U0126 preferentially increases cell dysfunction/death in mutant Htt-expressing cells when compared with controls, suggesting that the higher levels of activated ERK in mutant Htt-expressing cells are a protective cellular response. Increasing the levels of activated ERK in these cells by co-expression of a constitutive active MEK1 protects against cellular dysfunction/death, further reinforcing a protective role for ERK. Additional support comes from two separate studies. First, we find that treatment with a compound that increases ERK activation in the Htt14A2.5 line (CEP-11004) (43 -45) is also protective and this protection is at least partially due to ERK activation (unpublished data). Secondly, studies using orthovanadate, a phosphatase inhibitor, which reduces the dephosphorylation/ inactivation of ERK and other kinases, were found to result in decreased caspase 3 activation in Htt14A2.5 cells (data not shown) and reduced cell death in other HD PC12 cell models (54) .
A pro-survival role for ERK activation is consistent with a number of studies which suggest that ERK can mediate neuroprotective activities, following a number of neuronal insults including DNA damage, excitotoxicity, calcium overload, oxidative injury or hypoxia (reviewed in 55, 56) . Notably, a number of the above cellular processes are impacted upon mutant Htt expression, (reviewed in 3). In contrast to a potential protective role for ERK in neurons, several studies suggest that ERK activation can be detrimental to neurons and in particular contribute to neuronal degeneration (50) . For example, in a 6-hydroxydopamine model of Parkinson's disease, chronic ERK activation is associated with cell death and MEK inhibition exerts a protective effect (53) . Additionally, several Alzheimer's disease studies have shown a positive correlation between the amount of Ab and the level of ERK activation (reviewed in 53). In addition to eliciting pro-survival and pro-death responses in the nervous system, ERK has an important role in integrating CNS functions that require neuronal plasticity, such as long-term potentiation and depression, and in memory (19, 55) . Relevant to this proposed function, a recent study shows that transgenic mice susceptible to HD have very early problems with learning and memory prior to any movement phenotypes (57) .
Although studies investigating a role for ERK in HD are limited, there is support for an involvement of ERK activity in pathogenesis. In a Drosophila study, mutant Htt disrupted EGFR/ras/ERK signaling in glial cells, and reduced signaling through this pathway was associated with inclusion formation and reduced life span (14) . The complexity of the role of ERK signaling in HD is exemplified by the R6/2 transgenic mouse model (expressing a mutant Htt exon 1 protein) (58) . In this model, a progressive increase in ERK activation was found in the striatum (8-12 weeks), whereas in the cerebral cortex, the opposite was found. These results suggest distinct roles for activated ERK in these neuronal subtypes or that these cells respond uniquely to mutant Htt expression. One possibility is that the decreased ERK activation observed in cortical neurons is accompanied by decreased levels of BDNF, a downstream target of ERK. This in turn could result in reduced trophic support to striatal neurons, which may then mount a compensatory stress response and increase activated ERK in an attempt to prevent cell death. Consistent with the earlier observations and with this hypothesis, cortical neurons in HD patients exhibit reduced levels of BDNF, and consequently, its trophic effects upon striatal neurons appear to be reduced (59) .
The diversity of consequences of ERK activation is not surprising, as the ERK signaling pathway plays a pivotal role in numerous cellular functions, including proliferation, differentiation, migration and survival. It is probable that this diversity is likely to be mediated by a number of factors which are relevant to ERK activity within a given cell or tissue type, including the intensity and duration (e.g. transient, sustained or chronic) of activation, as well as the subcellular localization and presence of other signaling mediators (60) . These parameters are the basis for continued investigation of ERK in HD pathogenesis. However, the results presented here suggest that a possible therapeutic approach to prevent early neuronal dysfunction may involve upregulation of ERK activity.
MATERIALS AND METHODS
Propagation of cell lines and use of chemical inhibitors PC12 cells. Generation and propagation of the Htt14A2.5 line were performed as previously described (15) and cells were grown on collagen-coated plates (BD Biosciences). These lines express a truncated Htt peptide containing the first 17 amino acids and 103Qs fused in frame to EGFP (15) . A separate, independently derived, ecdysone-inducible PC12 cell line containing complete Htt exon 1 (Htt Q103 ¼ Httex1-103QP-EGFP) was also analyzed and has been previously described (27) . These cells were maintained in complete media (CM) with continued selection: Dulbecco's modified Eagle's medium (DMEM) (5% glucose) with 10% HS, 5% FBS, 1% penicillin/streptomycin and 200 mg/ml G418. Htt expression was induced with PA (5 mM for Htt14A2.5 cells and 2 mM for Htt 103 cells) for the indicated times. For chemical inhibitor experiments, cells were plated to 30-40% confluency in six-well plates.
ST14A cells. The parental (ST14A) and derived lines (N548wt and N548mu) were propagated as previously described (61) . Briefly, cells were plated at high density in six-well plates (1 Â 10 5 cells/well) in CM (DMEM/5% glucose, 10% FBS and 1% penicillin/streptomycin) at 338C. To inactivate the temperature-sensitive large T-antigen, cells were rinsed in phosphate-buffered saline (PBS) followed by shifting to SDM (SDM: DMEM-F12 containing 15 mM HEPES, L-glutamine, pyridoxine hydrochloride and N2 supplement) at 39 8 C. Inhibitors. U0126 (Calbiochem) was resuspended at 10 mM and SP600125 (Calbiochem) at 20 mM in dimethyl sulfoxide. For longer time courses, media and other components were changed every 2 days.
Htt14A2.5 sample preparation and microarrays
For total RNA preparation, 3 Â 10 5 cells were plated on 150 mm plates and the following day either induced with 5 mM PA or treated with ethanol alone (uninduced) for 48 h, followed by direct lysis using the RNeasy total RNA prep as described by the manufacturer (Qiagen, Valencia, CA, USA). Cells were harvested at 40 -60% confluency. RNA was quantitated spectrophotometrically and integrity tested by capillary electrophoresis (Agilent 2100 Bioanalyzer). Total RNA of 25 mg was used to generate target cRNAs for hybridization to Affymetrix Rat Genome U34A oligonucleotide arrays (UCI DNA Array Core Facility). Four separate cell growths were performed for Htt14A2.5 and PC12ec lines for the PA induced versus uninduced comparisons. Target cRNA was synthesized separately for each of these cell growths and hybridized individually to the oligonucleotide microarrays.
Microarray data analysis
For all the microarrays, the average fluorescence intensity was scaled to 500 arbitrary units so that chips could be directly compared and all 16 possible pairwise comparisons were made between the PA induced and the uninduced lines using the Affymetrix Microarray Suite v5.0 (Santa Clara, CA, USA). Genes were considered significant if 75% of the pairwise comparisons were called changed (i.e. difference call was increased, moderately increased or decreased and moderately decreased). MAS v5.0 signal log ratio values were converted to fold change values and averaged across all pairwise comparisons. Probe pairs were selected that had an average fold change of at least +1.5.
ERK and JNK activity assays p-ERK activity was measured using the PathDetect Elk1 trans-Reporting System (Stratagene, La Jolla, CA). Briefly, cells were plated in six-well plates and induced the following day with 5 mM PA. The next day cells were transfected as described earlier, using 50 ng of pFA2-Elk1 (fusion trans-activator plasmid) and 1 mg of pFR-Luc (reporter plasmid). Two days later (3 days of total induction), luciferase activity was measured using an Enhanced Luciferase Assay Kit as described by the manufacturer (BD Pharmingen) and readings performed using an Eritas microplate luminometer (Turner Biosystems, Sunnyvale, CA). Relative light unit (RLU) activity was corrected for variations in protein lysate concentrations.
p-JNK activity was measured from cell lysates using a c-Jun Terminal Kinase Assay Kit (Stratagene). Twenty micrograms of crude lysate was incubated with 4 mg GST-c-jun(1 -79), reaction buffer and 0.2 mCi [a-
32 P]ATP (6000 Ci/mmol) and incubated at 308C for 30 min. Reactions were stopped by adding sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) sample loading buffer, proteins were resolved on 12% SDS -polyacrylamide gels and the amount of 32 P incorporated into the substrate was quantitated by phosphoimager scanning.
Antibodies and immunoblots
Cell lysates were made and immunoblots were performed as previously described (15 ), total ERK, total c-jun and total JNK antibodies were from Cell Signaling Technology and all were used at a 1:1000 dilution. Quantitation of immnuoblots was performed using ImageJ 1.32j software from NIH.
